Related Experiment Video
Updated: Jan 25, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Cases in Precision Medicine: When Patients Present With Direct-to-Consumer Genetic Test Results
Michael G Artin1, Deborah Stiles1, Krzysztof Kiryluk1
1Columbia University, New York, New York (M.G.A., D.S., K.K., W.K.C.).
Abstract:
A couple is planning to start a family, and they decide to order a 23andMe test after reading about the company's carrier screening test and the new BRCA1/BRCA2 test. They bring the results to their internist for advice on how to proceed. Given the rise in public interest in human genetics and precision medicine, direct-to-consumer genetic testing is becoming increasingly popular, and clinicians should expect patients to present the results of these tests more frequently. This article uses a case scenario to provide information about what the results of these tests mean, and what they do not mean.
Related Concept Videos
What is Genetic Engineering?
Uncertainty in Measurement: Accuracy and Precision
Genetics of Speciation
What is Population Genetics?
Accuracy and Precision
Microorganisms in Medicine and Therapeutics

